Zhejiang Shengda Bio-pharm Co., Ltd. Class ASSE: 603079

Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025

· Issued by Zhejiang Shengda Bio-pharm Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment